Thermosensitization of tumor cells with inhibitors of chaperone activity and expression

Biomeditsinskaya Khimiya

Volumn 58, Issue 6, 2012, Pages 662-672

  Kudryavtsev, V A ^a   Makarova, Y M ^a   Kabakov, A E ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Heat shock proteins; HSF1; Hyperthermia; Thermoresistance

Indexed keywords

BENZOQUINONE DERIVATIVE; CHAPERONE; DITERPENE; DRUG DERIVATIVE; EPOXIDE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MACROCYCLIC LACTAM; MACROLIDE; PHENANTHRENE DERIVATIVE; QUERCETIN; QUERCITRIN; RADICICOL; TANESPIMYCIN; TRIPTOLIDE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; HELA CELL; HUMAN; HYPERTHERMIC THERAPY; METABOLISM; MOUSE;

ANIMALS; BENZOQUINONES; DITERPENES; EPOXY COMPOUNDS; FIBROBLASTS; HEAT-SHOCK PROTEINS; HELA CELLS; HSP27 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED; LACTAMS, MACROCYCLIC; MACROLIDES; MICE; MOLECULAR CHAPERONES; PHENANTHRENES; QUERCETIN;

EID: 84875774464     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: 10.18097/pbmc20125806662     Document Type: Article

References (21)

1. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gelermann J., Riess H., Felix R., Schlag P.M. (2002) Lancet Oncol., 3, 487-497.
2. Takahashil, Emi Y., Hasuda S., Kakeji Y., Naehara Y., Sugimachi K. (2002) Surgery, 131, S78-S84.
3. Hartl F.U., Haver-HartlM. (2002) Science, 295, 1852-1858.
4. Beer H.M. (2005) J. Clin. Invest., 115, 2633-2639.
5. Kampinga H.H. (1993) J. Cell Sei., 104, 11-17.
6. Calderwood S.K., Asea A. (2002) Int. J. Hyperthermia, 18, 597-608.
7. Calderwood S.K., Khaleque M.A., Sawyer D.B., Ciocca D.R. (2006) Trends Biochem. Sei., 31, 164-172.
8. Rossi A., Ciafre S., Balsamo M., Pierimarchi P., Santoro M. G. (2006) Cancer Res 66, 7678-7685.
9. Stravopodis D.J., Margaritis L.H., Voutsinas G.E. (2007) Curr. Med. Chem., 14 3122-3138.
10. Hwang M., Moretti L., Lu B. (2009) Curr. Med. Chem., 16, 3081-3092.
11. Kabakov A.E. (2009) in: Anticancer Drugs: Design, Delivery and Pharmacology (Spencer P., Holt W., cds.), Nova Science Publishers, New York, pp. 87-113.
12. Kabakov A. E., Kudryavtsev VA., Gabai V.L. (2010) J. Mol. Med., 88, 241-247.
13. Bagateli R., Paine-Murrieta G.D., Taylor C. W., Pulcini E.J., Akinaga S., Benjamin I.J., Whitesell L. (2000) Clin. Canccr Res., 6. 3312-3318.
14. McMillan D.R., XiaoX., Shao L., Graves K., Benjamin l.J. (1998) J. Biol. Chem , 273, 7523-7528.
15. Hosokawa N., Hirayoshi K., Kudo H., Takeshi H., Aoike A., Kawai K., Nagata K. (1992) Mol. Cell. Biol., 12, 3490-3498
16. Westerheide S.D., Kawahara T.L.A., Orton K., Morimoto R. f. (2007) J. Biol Chem., 281, 9616-9622.
17. Zaarur N.. Gabai V.L., Porco J.A., Calderwood S., Sherman M. Y. (2006) Canccr Res., 66. 1783-1791.
18. Michels A.A., Nguyen V.T., Konings A.W.T., Kampinga H.H., Bensaude O. (1995) Eur. J. Biochem., 234, 382-389.
19. Kampinga H.H., Kanon B., Salomons F.A., Kabakov A.E., Patterson C. (2003) Mol. Cell. Biol., 23, 4948-4958.
20. Kabakov A.E., Makarova Y.M., Malyutina Y.V. (2008) Int. J. Radiat. Oncol. Biol Phys., 71, 858-865.
21. Akimoto T., Nonaka T., Harashima K., Sakurai H., Ishikawa H., Mitsuhashi N. (2004)Int. J. Radiat. Biol., 80, 483-492.